Skip to content
AASLD Family of Websites: Liver Fellow Network
AASLD.org AASLD Foundation LiverLearning Career Center Journals The Liver Meeting HCV Guidelines
AASLD Logo
AASLD Logo

LFN Main Navigation

  • Topics
    Acute Liver Failure Alcohol-Associated Liver Disease Autoimmune Hepatitis Career Development and Mentorship Cholestatic Liver Disease Complications of Liver Disease and Portal Hypertension Drug-Induced Liver Disease HepMadness Inherited Disorders Liver Anatomy, Development, and Physiology Liver Infections Liver Physiology Liver Related Infections MASLD/MASH Neoplasms of the Liver Pathology Pediatrics Pregnancy-Related Liver Disease Symptoms and Clinical Presentation of Liver Disease and Portal HTN Systemic Conditions with Hepatic Manifestations Transplantation and Surgery Vascular Viral Hepatitis
  • Core Series
    Back to Basics Clinical Pearls Webinars Evidence Corner Pathology Pearls Podcast The Why? Series Tools of the Trade View All Core Series Practice Questions
  • Tweetorials
  • About
  • Core Series
  • Evidence Corner
  • SCOPE Index

SCOPE Index

October 23, 2022

Sindhu Pandurangi

Kayla Hartjes

Share

Copy Link Twitter Facebook

How does one prognosticate outcomes in pediatric primary sclerosing cholangitis? 

https://pubmed.ncbi.nlm.nih.gov/32464706/

Pediatrics Cholestatic Liver Disease

Share

Copy Link Twitter Facebook

Written By:

Sindhu Pandurangi

Kayla Hartjes

Related Content

Do Steroids Improve Outcomes After Kasai Hepatoportoenterostomy

September 13, 2022

Medical Therapies in Alagille Syndrome

April 18, 2022

A new second-line therapy for Primary Biliary Cholangitis: Elafibranor

December 13, 2024

AASLD LFN Logo

Follow Us

Disclaimer & Privacy Policy

© 2025 American Association for the Study of Liver Diseases